Opus Genetics (IRD) Capital Expenditures (2010 - 2019)
Opus Genetics (IRD) reported Capital Expenditures of $5617.0 for Q4 2019, down 9.43% on a QoQ basis from $6202.0 in Q2 2019.
Opus Genetics (IRD) has 9 years of Capital Expenditures data on file, last reported at $5617.0 in Q4 2019.
- Quarterly Capital Expenditures changed N/A year-over-year to $5617.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $25000.0 (down 36.26% YoY) and the FY2019 annual result came in at $25000.0, down 36.26% from the prior year.
- Capital Expenditures eased to $5617.0 in Q4 2019 per IRD's latest filing, from $6202.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $53799.0 in Q4 2017 and bottomed at $403.0 in Q4 2016.
- The 5-year median for Capital Expenditures is $5106.5 (2016), against an average of $11686.7.
- The widest annual swing landed in 2016, when Capital Expenditures slumped 98.13%; it then soared 13249.63% in 2017.
- Tracing IRD's Capital Expenditures over 5 years: stood at $9803.0 in 2015, then tumbled by 95.89% to $403.0 in 2016, then soared by 13249.63% to $53799.0 in 2017, then tumbled by 33.58% to $35731.0 in 2018, then slumped by 84.28% to $5617.0 in 2019.
- Per Business Quant, the three latest IRD Capital Expenditures figures stand at $5617.0 (Q4 2019), $6202.0 (Q2 2019), and $13181.0 (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 5,617.00 |
| Dec 31, 2019 | 5,617.00 |
| Jun 30, 2019 | 6,202.00 |
| Jun 30, 2019 | 6,202.00 |
| Mar 31, 2019 | 13,181.00 |
| Mar 31, 2019 | 13,181.00 |
| Sep 30, 2018 | 35,731.00 |
| Sep 30, 2018 | 35,731.00 |
| Jun 30, 2018 | 973.00 |
| Jun 30, 2018 | 973.00 |
| Mar 31, 2018 | 2,520.00 |
| Mar 31, 2018 | 2,520.00 |
| Dec 31, 2017 | 53,799.00 |
| Dec 31, 2017 | 53,799.00 |
| Sep 30, 2017 | 3,459.00 |
| Sep 30, 2017 | 3,459.00 |
| Jun 30, 2017 | 13,945.00 |
| Jun 30, 2017 | 13,945.00 |
| Mar 31, 2017 | 3,965.00 |
| Mar 31, 2017 | 3,965.00 |
| Dec 31, 2016 | 403.00 |
| Dec 31, 2016 | 403.00 |
| Sep 30, 2016 | 752.00 |
| Sep 30, 2016 | 752.00 |
| Jun 30, 2016 | 2,915.00 |
| Jun 30, 2016 | 2,915.00 |
| Mar 31, 2016 | 4,596.00 |
| Mar 31, 2016 | 4,596.00 |
| Dec 31, 2015 | 9,803.00 |
| Dec 31, 2015 | 9,803.00 |
| Sep 30, 2015 | 40,111.00 |
| Sep 30, 2015 | 40,111.00 |
| Jun 30, 2015 | 4,453.00 |
| Jun 30, 2015 | 4,453.00 |
| Mar 31, 2015 | 7,935.00 |
| Mar 31, 2015 | 7,935.00 |
| Dec 31, 2014 | 11,095.00 |
| Dec 31, 2014 | 11,095.00 |
| Sep 30, 2014 | 15,940.00 |
| Sep 30, 2014 | 15,940.00 |
| Jun 30, 2014 | 10,443.00 |
| Jun 30, 2014 | 10,443.00 |
| Mar 31, 2014 | 3,771.00 |
| Mar 31, 2014 | 3,771.00 |
| Dec 31, 2013 | 3,690.00 |
| Dec 31, 2013 | 3,690.00 |
| Sep 30, 2013 | 44,850.00 |
| Sep 30, 2013 | 44,850.00 |
| Jun 30, 2013 | 1,000.00 |
| Jun 30, 2013 | 1,000.00 |
| Mar 31, 2013 | 609.00 |
| Mar 31, 2013 | 609.00 |
| Dec 31, 2011 | 11,636.00 |
| Dec 31, 2011 | 11,636.00 |
| Sep 30, 2011 | 2,257.00 |
| Sep 30, 2011 | 2,257.00 |
| Jun 30, 2011 | 2,154.00 |
| Jun 30, 2011 | 2,154.00 |
| Dec 31, 2010 | 1,502.00 |
| Dec 31, 2010 | 1,502.00 |
| Sep 30, 2010 | 747.00 |
| Sep 30, 2010 | 747.00 |